{"id":769064,"date":"2025-10-16T11:09:01","date_gmt":"2025-10-16T11:09:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=769064"},"modified":"2025-10-16T11:09:01","modified_gmt":"2025-10-16T11:09:01","slug":"pharmaceutical-drug-delivery-market-to-reach-usd-25460-billion-by-2029-driven-by-technological-advancements-and-rising-chronic-disease-burden","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pharmaceutical-drug-delivery-market-to-reach-usd-25460-billion-by-2029-driven-by-technological-advancements-and-rising-chronic-disease-burden_769064.html","title":{"rendered":"Pharmaceutical Drug Delivery Market to Reach USD 2,546.0 Billion by 2029, Driven by Technological Advancements and Rising Chronic Disease Burden"},"content":{"rendered":"
\n
\"Pharmaceutical<\/a><\/div>\n
\n
Asia Pacific is expected to register the highest growth rate in the coming years, driven by the presence of leading pharmaceutical companies, a growing patient population with chronic conditions, increased healthcare spending, and government efforts to enhance access to pharmaceutical treatments in the region.<\/div>\n<\/div>\n<\/div>\n
The pharmaceutical drug delivery market is segmented by facility of use, including hospitals, ambulatory surgical centers, diagnostic centers, home care settings, and other facilities.<\/div>\n

The global pharmaceutical drug delivery market<\/a><\/strong> is projected to grow from USD 1,949.4 billion in 2024<\/strong> to USD 2,546.0 billion by 2029<\/strong>, registering a CAGR of 5.5%<\/strong>, according to the latest report by MarketsandMarkets™<\/strong>. This growth is fueled by the rising prevalence of chronic diseases<\/strong>, increased product launches<\/strong>, enhanced pharmaceutical R&D investments<\/strong>, and government initiatives<\/strong> supporting affordable and efficient drug delivery systems.<\/p>\n

Technological innovations, growing patient preference for home-based care<\/strong>, and favorable reimbursement policies<\/strong> are further propelling the market forward. However, challenges such as needlestick injury risks<\/strong> associated with injectables and pricing pressures<\/strong> from government regulations continue to restrain the pace of expansion.<\/p>\n

Download PDF Brochure: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=1085<\/strong><\/a><\/p>\n

Injectable Drug Delivery Sector Leading the Market<\/strong><\/p>\n

Injectable drug delivery holds the largest market share among administration routes, primarily due to its effectiveness in managing chronic diseases. Injectables offer advantages over oral medications by improving patient adherence and reducing dosing frequency. Advances in injectable technologies, aimed at minimizing needle pain and complications, are further fueling growth in this segment.<\/p>\n

Hospitals to Experience Rapid Market Expansion<\/strong><\/p>\n

The pharmaceutical drug delivery market is segmented by facility of use, including hospitals, ambulatory surgical centers, diagnostic centers, home care settings, and other facilities. Hospitals are projected to see the most substantial growth due to high patient traffic, increased need for various medications and delivery devices, a rise in surgeries, and a growing prevalence of chronic diseases, which are driving up hospital admissions and, consequently, the demand for drug delivery solutions.<\/p>\n

Asia Pacific Region Poised for Significant Growth<\/strong><\/p>\n

The pharmaceutical drug delivery market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is expected to register the highest growth rate in the coming years, driven by the presence of leading pharmaceutical companies, a growing patient population with chronic conditions, increased healthcare spending, and government efforts to enhance access to pharmaceutical treatments in the region.<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=1085<\/strong><\/a><\/p>\n

Major Market Players and Their Strategies<\/strong><\/p>\n

Prominent players in the pharmaceutical drug delivery market include Johnson & Johnson Services, Inc. (US), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Sanofi (France), Bayer AG (Germany), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A\/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim International GmbH (Germany), and AstraZeneca (UK).<\/p>\n

 <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets\u2122 Research Private Ltd.<\/a>
Contact Person:<\/strong> Mr. Rohan Salgarkar
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City:<\/strong> Florida
State:<\/strong> Florida
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/drug-delivery-technologies-market-1085.html<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Asia Pacific is expected to register the highest growth rate in the coming years, driven by the presence of leading pharmaceutical companies, a growing patient population with chronic conditions, increased healthcare spending, and government efforts to enhance access to pharmaceutical … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-769064","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/769064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=769064"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/769064\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=769064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=769064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=769064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}